BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36734437)

  • 1. Immunohistochemical positive regulatory domain member 10 expression in soft tissue sarcomas.
    Mistik O; Sayar H
    Pol J Pathol; 2022; 73(3):223-232. PubMed ID: 36734437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 Cases.
    Puls F; Pillay N; Fagman H; Palin-Masreliez A; Amary F; Hansson M; Kindblom LG; McCulloch TA; Meligonis G; Muc R; Rissler P; Sumathi VP; Tirabosco R; Hofvander J; Magnusson L; Nilsson J; Flanagan AM; Mertens F
    Am J Surg Pathol; 2019 Apr; 43(4):504-513. PubMed ID: 30570551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile.
    Hofvander J; Puls F; Pillay N; Steele CD; Flanagan AM; Magnusson L; Nilsson J; Mertens F
    J Pathol; 2019 Dec; 249(4):425-434. PubMed ID: 31313299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent PRDM10 gene fusions in undifferentiated pleomorphic sarcoma.
    Hofvander J; Tayebwa J; Nilsson J; Magnusson L; Brosjö O; Larsson O; Vult von Steyern F; Mandahl N; Fletcher CD; Mertens F
    Clin Cancer Res; 2015 Feb; 21(4):864-9. PubMed ID: 25516889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
    Perret R; Michal M; Carr RA; Velasco V; Švajdler M; Karanian M; Meurgey A; Paindavoine S; Soubeyran I; Coindre JM; Boidot R; Charon-Barra C; Geneste D; Weingertner N; Pissaloux D; Tirode F; Baud J; Le Loarer F
    Histopathology; 2021 Nov; 79(5):810-825. PubMed ID: 34121219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent PRDM10 Fusions in Superficial CD34-Positive Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 10 Additional Cases of an Emerging Novel Entity.
    Zhao M; Yin X; He H; Fan Y; Ru G; Meng X
    Am J Clin Pathol; 2023 Apr; 159(4):367-378. PubMed ID: 36812381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor.
    Puls F; Carter JM; Pillay N; McCulloch TA; Sumathi VP; Rissler P; Fagman H; Hansson M; Amary F; Tirabosco R; Magnusson L; Nilsson J; Flanagan AM; Folpe AL; Mertens F
    Mod Pathol; 2022 Jun; 35(6):767-776. PubMed ID: 34969957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of SynCAM3 and cyclin D1 immunohistochemistry in distinguishing superficial CD34-positive fibroblastic tumor from its histological mimics.
    Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Murahashi Y; Emori M; Tsuyuki A; Hasegawa T
    Med Mol Morphol; 2023 Mar; 56(1):69-77. PubMed ID: 36344703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
    Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
    Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial CD34 fibroblastic tumors and PRDM10-rearranged soft tissue neoplasm: An evolving diagnosis.
    Johnson C; Parsa L; Gibbs J; Sligh J
    J Cutan Pathol; 2024 Jan; 51(1):11-14. PubMed ID: 37150806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undifferentiated and dedifferentiated soft tissue neoplasms: Immunohistochemical surrogates for differential diagnosis.
    Thway K; Fisher C
    Semin Diagn Pathol; 2021 Nov; 38(6):170-186. PubMed ID: 34602314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superficial CD34-Positive Fibroblastic Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Study of 59 Cases.
    Anderson WJ; Mertens F; Mariño-Enríquez A; Hornick JL; Fletcher CDM
    Am J Surg Pathol; 2022 Oct; 46(10):1329-1339. PubMed ID: 35713642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
    Franchi A; Massi D; Santucci M
    Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
    Massi D; Beltrami G; Capanna R; Franchi A
    Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
    Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
    Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High IGF2 and FGFR3 are associated with tumour progression in undifferentiated pleomorphic sarcomas, but EGFR and FGFR3 mutations are a rare event.
    Rüping K; Altendorf-Hofmann A; Chen Y; Kampmann E; Gibis S; Lindner L; Katenkamp D; Petersen I; Knösel T
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1315-22. PubMed ID: 24804818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global translation during early development depends on the essential transcription factor PRDM10.
    Han BY; Seah MKY; Brooks IR; Quek DHP; Huxley DR; Foo CS; Lee LT; Wollmann H; Guo H; Messerschmidt DM; Guccione E
    Nat Commun; 2020 Jul; 11(1):3603. PubMed ID: 32681107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
    Koelsche C; Renner M; Hartmann W; Brandt R; Lehner B; Waldburger N; Alldinger I; Schmitt T; Egerer G; Penzel R; Wardelmann E; Schirmacher P; von Deimling A; Mechtersheimer G
    J Exp Clin Cancer Res; 2014 Apr; 33(1):33. PubMed ID: 24726063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soft tissue sarcomas: From a morphological to a molecular biological approach.
    Oda Y; Yamamoto H; Kohashi K; Yamada Y; Iura K; Ishii T; Maekawa A; Bekki H
    Pathol Int; 2017 Sep; 67(9):435-446. PubMed ID: 28759137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy: Overlapping Genetic Features With Clear Cell Sarcoma of Kidney.
    Kao YC; Sung YS; Zhang L; Huang SC; Argani P; Chung CT; Graf NS; Wright DC; Kellie SJ; Agaram NP; Ludwig K; Zin A; Alaggio R; Antonescu CR
    Am J Surg Pathol; 2016 Aug; 40(8):1009-20. PubMed ID: 26945340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.